Menu
  • CAR T-Cell Therapy

    Rutgers Cancer Institute in conjunction with Robert Wood Johnson University Hospital New Brunswick, an RWJBarnabas Health facility, are now offering CAR T-cell therapy for forms of B-cell lymphoma.  Learn more about this ‘living drug.’

  • New Jersey’s Only

    Rutgers Cancer Institute, the state’s only Comprehensive Cancer Center as designated by the National Cancer Institute, has been awarded a $15.1 million grant as part of its successful redesignation. New Jersey Governor Phil Murphy, 10-year old cancer survivor Grace Eline and other dignitaries shared what that means for the Garden State. Learn more

  • An Expansion of Care

    RWJBarnabas Health and Rutgers Cancer Institute, in partnership with New Brunswick Development Corporation announced the development of a new, state-of-the-art, free-standing cancer pavilion in New Brunswick. Learn more

  • Celebrating Cancer Survivors

    Rutgers Cancer Institute in partnership with RWJBarnabas Health and Six Flags Great Adventure unveiled the first coaster wrapped in the handprints of cancer survivors & supporters. Learn more about the Coasters for Cancer initiative

  • ‘Out of the Box’ Care

    When diagnosed with advanced stage endometrial cancer, Irma Lopez found a clinical trial just right for her thanks to teamwork by the Gynecologic Oncology and Phase 1/Investigational Therapeutics Programs at Rutgers Cancer Institute. Read more

  • Rutgers Cancer Institute Docs Named ‘Tops’

    Several physicians from Rutgers Cancer Institute have been named among ‘New Jersey’s Top Doctors in Cancer Care’ by Castle Connolly. Learn who made this year’s list

image that says give now and support cancer research with link to giving page

 

 

 

 

Logo for ScreenNJ program and link to website

 

 

 

 

Robert Wood Johnson Barnabas Health logo with link to Partners page

 

  

 

 

 

Big Ten Cancer Research Consortium

 

 

 

 

Rutgers Health

 

Recent News

Visit our newsroom

two diverse young girls on an outside courtRutgers Cancer Institute radiation oncologist Rahul Parikh and colleagues find racial disparities in survival outcomes for pediatric Hodgkin lymphoma patients. Learn more


Athena Kritharis headshotPhysician-scientists at Rutgers Cancer Institute of New Jersey are at the forefront of studying the causes of leukemia and developing new treatment options for blood cancers. Learn more


Rutgers Cancer Institute physician-scientists Shridar Ganesan, MD, PhD, and Andrew M. Evens, DO, MSc, FACP, are collaborating on national research projects that received $1.5 million in combined funding from the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program. Learn more


Rutgers Cancer Institute of New Jersey pediatric hematologist/oncologist Scott Moerdler, MD, has received a $50,000 grant to help identify new prognostic markers and potential therapeutic targets in pediatric Hodgkin lymphoma. Learn more


Several physicians from Rutgers Cancer Institute have been named among ‘New Jersey’s Top Doctors in Cancer Care’ by Castle Connolly. Learn who made this year’s list


More than $2 million in grants recently awarded to Rutgers Cancer Institute of New Jersey resident researcher Daniel Herranz Benito, PhD, will support examination of potential treatment targets for a rare and aggressive blood cancer. Read more


Three young adults outsideAnxiety and depression related to childhood cancer survivorship can be challenging. Rutgers Cancer Institute recently educated survivors about these topics with support from the National Children’s Cancer Society. Learn more

 

 

 



 

image that says give now and support cancer research with link to giving page

 

 

 

 

Logo for ScreenNJ program and link to website

 

 

 

 

Robert Wood Johnson Barnabas Health logo with link to Partners page

 

  

 

 

 

Big Ten Cancer Research Consortium

 

 

 

 

Rutgers Health